In-Person CME Webcast
1.00 CME/CE Credit
What Are You Afraid Of? Prescribing Hormone Therapy with Confidence!
Menopause is an inevitable life stage for half the population, yet it remains one of the most underdiagnosed and undertreated areas of primary care. Rachel Rubin, MD, has emerged as a leading national voice in menopause care, reframing how clinicians approach midlife women’s health, sexuality, and evidence-based hormone therapy. In this keynote, Dr. Rubin will examine how historical gaps in education and misinterpretation of early data — particularly from the Women’s Health Initiative — have shaped persistent fear and confusion around menopause hormone therapy.
Dr. Rubin will provide a practical, evidence-based framework for understanding the physiologic changes of menopause, with special attention to genitourinary syndrome of menopause (GSM) and sexual health — areas frequently overlooked in routine care. This session will equip primary care clinicians with the knowledge and confidence to initiate meaningful conversations, dispel outdated myths, and integrate modern menopause care into everyday practice to improve quality of life, comfort, and sexual well-being for midlife and aging women.
CME/CE Information
1.00 AMA PRA Category 1 Credits™ or 1.00 CBRN contact hours or 1.00 AANP, including 0.40 AANP Pharm
Release Date: 4/9/2026
Expiration Date: 5/29/2026
Topics
Faculty
Learning Objectives
- Describe the physiologic effects of menopause on the body, including the genitourinary tract and sexual function
- Recognize common but underreported symptoms of perimenopause and menopause and their impact on quality of life
- Explain the historical context of the Women’s Health Initiative and how updated evidence informs current individualized hormone therapy decisions
- Apply the five key tenets of menopause management — estrogen, progesterone, testosterone, GSM treatment, and sexual health — in primary care practice
- Initiate patient-centered conversations about menopause and sexuality with greater confidence and clinical clarity
Faculty
Rachel Rubin, MD
Urologist & Sexual Medicine Specialist
Assistant Clinical Professor of Urology, Georgetown University
Learn MoreDisclosures
The following relevant financial relationships have been disclosed by those in a position to influence the content of this activity. All have been mitigated by Pri-Med Institute:
Rachel Rubin, MD: Consultant for Sprout Pharmaceuticals, SoftwaveTRT; Independent Contractor for Materna Medical
James Q. Simmons, DNP, MSN, RN, AG/ACNP-BC (Moderator): Speaker for Pfizer
All others in control of content for this activity have disclosed no relevant financial relationships.
CME/CE Information
AMA PRA Category 1 Credits™
Accreditation Statement
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CBRN contact hours
Accreditation Statement
Provider approved by the California Board of Registered Nursing, Provider Number 17615, for 1.00 contact hours.
AANP
Accreditation Statement
Pri-Med Institute is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 040308.
Designation Statement
This activity is approved for 1.00 contact hour of continuing education, which includes 0.4 hours of pharmacology.
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.